Europe — EMA

Olmesartan Medoxomil Jubilant

Request sourcing

Pack/s

What is Olmesartan Medoxomil?

Olmesartan Medoxomil, the active ingredient in Olmesartan Medoxomil Jubilant, is an angiotensin II receptor blocker presented as a tablet for oral use. It is employed in the management of hypertension in adult patients. GNH USA supplies Olmesartan Medoxomil Jubilant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Medoxomil Jubilant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil used for?

Olmesartan Medoxomil is an angiotensin II receptor blocker indicated for several cardiovascular indications.

- Hypertension: lowers blood pressure and reduces the risk of cardiovascular events. - Heart failure: used as part of combination therapy to improve symptoms and outcomes. - Diabetic nephropathy: helps protect kidney function by controlling blood pressure. - Post‑myocardial infarction: contributes to long‑term blood pressure control after a heart attack. - Stroke prevention: assists in reducing the risk of recurrent stroke in patients with hypertension.

What are the side effects of Olmesartan Medoxomil?

Common Side Effects: - Dizziness - Headache - Fatigue - Nasal congestion - Diarrhea - Upper respiratory troubles

Serious or Rare Side Effects: - Angio‑ - - ... - ... ... ... ... ... ... ... ... … … … … … - … ... … … … ... … - ... ... … … … … … … - … … … ... … … … … … … - ... … … … … - ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →